Skip to main content
Insights into Imaging
Fig. 16 | Insights into Imaging

Fig. 16

From: How clinical imaging can assess cancer biology

Fig. 16

A 56-year-old woman with an invasive ductal carcinoma of the breast. Pretherapy (a) the sagittal reformatted maximum intensity projection (MIP) image from DCE-MRI (left) demonstrating a 5-cm enhancing mass (white arrow). MR spectrum (right) depicts a marked choline peak (red arrow). Images obtained after chemotherapy and anti-HER2 therapy with trastuzumab (b) evidenced a residual lesion. Sagittal reformatted maximum intensity projection (MIP) image from DCE-MRI demonstrated discrete dots of enhancement (white arrow), while MR spectrum showed a decreased choline peak (red arrow). Tumorectomy revealed residual fibrosis without tumor cells

Back to article page